Orogentx
1 known investors
Find your way into Orogentx
Orogen Therapeutics uses AI and machine learning to accelerate drug discovery, focusing on small molecule candidates for immuno-inflammatory diseases. The company combines computational chemistry, DNA-encoded library technology, and medicinal expertise to develop novel therapeutic medicines.
Founders & leadership
MP
Mark PykettChief Executive Officer
Investors · 1
Frequently asked questions
- What does Orogentx do?
- Orogen Therapeutics uses AI and machine learning to accelerate drug discovery, focusing on small molecule candidates for immuno-inflammatory diseases. The company combines computational chemistry, DNA-encoded library technology, and medicinal expertise to develop novel therapeutic medicines.
- Who are Orogentx's investors?
- Orogentx's investors include Novalis LifeSciences.